This article is more than 5 years old. Information may no longer be current.
No differences seen with anti-inflammatory drops after SLT
Click Here to Manage Email Alerts
Anti-inflammatory drops did not make a significant difference in pain, redness, cells in the anterior chamber or peak IOP in patients who underwent selective laser trabeculoplasty, according to a study.
Researchers included 132 patients with primary open-angle glaucoma, normal-tension glaucoma or ocular hypertension in the prospective, randomized clinical trial. All patients underwent SLT in both eyes. One eye of each patient was treated after surgery with either indomethacin 0.1% or dexamethasone 0.1% three times a day for 1 week, and the other eye did not receive any anti-inflammatory treatment.
IOP and inflammation were noted at 1 hour, 1 week, and 1, 3 and 6 months after SLT.
There was no significant difference between the treated groups and the control groups or between the two treatment groups at any time point in terms of pain, redness, cells in the anterior chamber and IOP-lowering effect.
The researchers concluded that the inflammation induced by SLT is small and short-lived and that the use of anti-inflammatory drops after SLT made did not make a difference in outcomes. – by Robert Linnehan
Disclosure: The authors report no relevant financial disclosures.
Click Here to Manage Email Alerts